Drug Approval | April 26, 2022
USFDA approves first Covid-19 treatment for young children
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
This action makes Veklury the first approved Covid-19 treatment for children less than 12 years of age
A Promising Innovative Medicine (PIM) designation is an early indication that leniolisib is a candidate for the MHRA's Early Access to Medicines Scheme
Desidustat is currently approved only in India as OxemiaTM for patients with CKD induced anemia
The tablets are available in 100 mg strength in bottle count sizes of 60
The latest technology from ZEISS empowers surgeons with one complete, digitally integrated cataract workflow for efficiency without compromise
The MicroGEM Saliva test is the first point of care PCR saliva test for Covid-19 delivering results in minutes
The HD-550 endoscopy system has been available outside of the USA since 2019
Marks the second of three biosimilars Amneal expects to receive U.S. approval for in 2022
This product will be manufactured at Lupin’s Nagpur facility in India
The product will be manufactured at Lupin’s facility in Goa, India
Subscribe To Our Newsletter & Stay Updated
